In Pic: The team of heart transplant surgeons felicitating the transplant patients from Left to Right - Dr. Govini Balasubramani Sr. Consultant, C.T.V.S, Dr. Gauthaman, Medical Director, Mr. Rakesh (Transplant Recpient), Mr. Ramesh (Transplant Recpient), Mr. Hemraj Parmar, COO, Dr. Arun, Cardiologist, Dr. Rahul Chandola, Sr. Consultant CTVS are seen in the picture.
Awareness among the public, financial constraints and number of centers performing transplants are the major challenges in India
Chennai, 04th May: Longevity after a heart transplant is the yard stick for measuring the success of a heart transplant globally. In U.S almost 3.5 lakh patients suffer from end stage heart diseases. Heart Transplantations carried out amounts to 3500 per year. The requirement in India is almost 10 folds higher but the number of transplant surgeries performed is not more than 200 a year.
Heart transplantation, has evolved into a treatment of choice for many people with severe heart failure who have severe symptoms despite maximum medical therapy. Survival among heart transplant recipients has improved as a result of improvements in treatments that suppress the immune system and prevent infection.
The lives and hope of three men from Andhra Pradesh, Chennai and Chhattisgarh, who were suffering from end-stage diseases of Heart, were kept alive at Global Health City in spite of financial constraints and other challenges, with the successful complex heart transplantations.
Mr. Narayana, a 56 year old gentleman from Ongole, Andhra Pradesh had been suffering from Dilated Cardio Myopathi. A 30 year old donor organ received fortunately to save the life of Mr. Narayana, now he is on his fifth year after transplant hale and healthy.
Mr. Ramesh, a 43 year old gentleman from Chennai had been suffering from severe heart failure. The heart failure had progressed to a level, where it had caused liver decompensation (Liver Cirrhosis). Luckily he had a suitable donor.
Mr. Rakesh, a 37 year old gentleman hailing from Chhattisgarh, had been suffering from severe heart failure. The heart failure had progressed to an end stage, where it had lead to Dilated Cardiomayopathy.
Dr. Rahul Chandola – Senior Consultant Heart & Lung Transplant Surgeon said “Heart transplant is an excellent treatment modality for patients with heart failure that gives great survival out comes and good quality of life out to many many years. There is a sheer need for awareness about this life changing modality amongst the patients and physicians alike. A great example is Mr. Rakesh who hails from Chhattisgarh and was suffering from heart failure.
He got referred to a reputed hospital in Vellore, where he was told that he’s got only few months to live and suggested terminal care for him. Later he approached us for a second opinion where he was offered heart transplantation that was carried out successfully and now his quality of life has changed completely. We are stepping up to create corpus funds from the affordable public / organizations to realize the dream of offering non affordable patients like Mr. Rakesh, Mr. Ramesh, Mr. Narayana and many more in the near future.”
Dr. Govini Balasubramani – Senior Consultant Heart & Lung Transplant Surgeon said, “In India Chennai is considered as Mecca of organ transplantations. There are three major factors influencing heart transplants in India, awareness among the public, financial constraints and the number of centers performing transplants.
All the three patients here had affordability issues for their transplantation. I strongly believe that India can surpass United States in terms of heart transplantations in the year 2022. Duly addressing the mentioned issues will make us global leader in heart transplantation.”
Highlighting the uniqueness of the transplants, Dr. K. Ravindranath – Chairman, Global Hospitals Group added “Over the years, Global Health City had become the most preferred organ transplant centre and is one of the largest multi-organ transplant centers in India adding to many first-of-its-kind transplant surgeries.
Today with a series of high risk heart transplants, Global Heart and Lung Institute had once again demonstrated its constant endeavor to offer the best possible treatment to patients by combining contemporary technology and processes. Challenges faced by.”
